GlassScriptPhysician profile
David S Peizner
NPI 1245235233
$1,491.15
in general payments reported to CMS, 2019-2025
21 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $53.56 · 2021: $108 · 2022: $106 · 2023: $209 · 2024: $232 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $407.76 | 2019-2025 | Impella |
| Boston Scientific Corporation | $215.16 | 2024-2025 | Rotapro, Avvigo Guidance System, Versacross Large Access Solution |
| E.R. Squibb & Sons, L.L.C. | $121.43 | 2019-2023 | Eliquis |
| Philips North America LLC | $117.43 | 2019-2023 | |
| Edwards Lifesciences Corporation | $85.84 | 2023-2025 | Pascal, Sapien 3 Ultra Resilia |
| Pfizer INC. | $75.14 | 2019-2025 | |
| Inari Medical, INC. | $66.88 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $56.61 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $51.51 | 2023-2025 | Verquvo |
| Abbott Laboratories | $39.84 | 2019-2024 | Perclose Prostyle |
| Shockwave Medical, INC | $37.50 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $33.70 | 2019 | |
| Ekos Corporation | $30.10 | 2019 | |
| Terumo Medical Corporation | $26.51 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.25 | 2025 | Lifevest |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $21.74 | 2022 | |
| Impulse Dynamics (USA) INC. | $18.81 | 2023 | Optimizer |
| Amgen INC. | $16.71 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.94 | 2024 | Lokelma |
| Teleflex LLC | $15.26 | 2023 | Supercross |
| Cook Medical LLC | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Peizner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.